Novavax CEO on vaccine timeline: It’s taking us longer than expected

Novavax delayed its timeline for ramping up the company's COVID-19 vaccine production until the latter half of 2021. Novavax President and CEO Stanley Erck joins Yahoo Finance Live to discuss.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting